The Italian Billionaire Family Making Glass Vials For Covid Vaccines Scores With U.S. IPO The 72-year-old firm based in northern Italy debuted on the New York Stock Exchange in a rare public listing for an Italian company, adding $550 million to the Stevanato family’s coffers.